Abstract
After pulmonary artery (PA) patch augmentation, surgical or catheterization reintervention to address PA stenosis is not uncommon. Multiple patch materials are available and the need for reintervention may be related to characteristics of the patch material. In this retrospective chart review of patients who underwent PA augmentation from 2004 through 2013, we compare outcomes after PA augmentation with standard patch (SP) material and extracellular matrix (ECM) patch material. The primary outcome was reintervention-free survival (surgery or catheterization) using Kaplan–Meier survival analysis with the log-rank test. Risk factors for reintervention were assessed with Cox proportional hazard analyses. Baseline characteristics between groups were similar, except single-ventricle (SV) patients were more likely to have SP, and duration of follow-up was longer in the SP group. Median time to reintervention for all patients was 1099 days (95 % CI 646–1552 days). There was no difference in reintervention-free survival between the patch groups (p = 0.12); however, in multivariable analysis controlling for surgeon and patch, longer reintervention-free survival was associated with SV physiology (HR 0.57 95 % CI 0.34–0.95, p = 0.03) and aortic cross-clamp (XC) use (HR 0.52, 95 % CI 0.32–0.84, p = 0.008). Since there is no difference in median time to reintervention following PA augmentation with SP or ECM, patch choice should be determined by other factors, such as surgeon preference and cost. Longer reintervention-free survival in SV patients may be related to the set schedule of staged palliation. XC use may allow more extensive PA augmentation, thus protecting against the need for reintervention.
Similar content being viewed by others
References
Nakano T, Fukae K, Sonoda H, Tachibana T, Kajimoto M, Ando Y et al (2008) Follow-up study of pulmonary artery configuration in hypoplastic left heart syndrome. Gen Thoracic Cardiovasc Surg 56:54–61
Mimic B, Brown KL, Oswal N, Simmonds J, Hsia TY, Tsang VT et al (2014) Neither age at repair nor previous palliation affects outcome in tetralogy of Fallot repair. Eur J Cardiothorac Surg 45:92–98
Oda S, Nakano T, Sugiura J, Fusazaki N, Ishikawa S, Kado H (2012) Twenty-eight years’ experience of arterial switch operation for transposition of the great arteries in a single institution. Eur J Cardiothorac Surg 42:674–679
Spiegelenberg SR, Hutter PA, van de Wal HJ, Hitchcock JF, Meijboom EJ, Harinck E (1995) Late re-interventions following arterial switch operations in transposition of the great arteries. Incidence and surgical treatment of postoperative pulmonary stenosis. Eur J Cardiothorac Surg 9:7–10; Discussion 10–1
Robinson KA, Li J, Mathison M, Redkar A, Cui J, Chronos NA et al (2005) Extracellular matrix scaffold for cardiac repair. Circulation 112:I135–I143
Wainwright JM, Hashizume R, Fujimoto KL, Remlinger NT, Pesyna C, Wagner WR et al (2012) Right ventricular outflow tract repair with a cardiac biologic scaffold. Cells Tissues Organs 195:159–170
Scholl FG, Boucek MM, Chan KC, Valdes-Cruz L, Perryman R (2010) Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease. World J Pediatr Congenit Heart Surg 1:132–136
Witt RG, Raff G, Van Gundy J, Rodgers-Ohlau M, Si MS (2013) Short-term experience of porcine small intestinal submucosa patches in paediatric cardiovascular surgery. Eur J Cardiothorac Surg 44:72–76
Weber SS, Annenberg AJ, Wright CB, Braverman TS, Mesh CL (2014) Early pseudoaneurysm degeneration in biologic extracellular matrix patch for carotid repair. J Vasc Surg 59:1116–1118
Wyler von Ballmoos M, Murtaza G, Gasparri M, Masroor S (2013) Reconstruction of the right atrium using an extracellular matrix patch in a patient with severe mediastinal aspergillosis. Int J Surg Rep 4:290–292
Zaidi AH, Nathan M, Emani S, Baird C, del Nido PJ, Gauvreau K et al (2014) Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: histologic evaluation of explanted valves. J Thorac Cardivasc Surg 5:2216–2225.e1
Padalino MA, Quarti A, Angeli E, Frigo AC, Vida VL, Pozzi M et al (2015) Early and mid-term clinical experience with extracellular matrix scaffold for congenital cardiac and vascular reconstructive surgery: a multicentric Italian study. Interact Cardiovasc Thorac Surg 1:40–49
Yanagawa B, Rao V, Yau TM, Cusimano RJ (2014) Potential myocardial regeneration with CorMatrix ECM: a case report. J Thorac Cardivasc Surg 4:e41–e43
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Bacha is a member of the CorMatrix® Advisory Board.
Human Participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Y. Fraint, H., E. Richmond, M., A. Bacha, E. et al. Comparison of Extracellular Matrix Patch and Standard Patch Material in the Pulmonary Arteries. Pediatr Cardiol 37, 1162–1168 (2016). https://doi.org/10.1007/s00246-016-1413-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-016-1413-8